Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimethaphan for Supine Hypertension in Multiple System Atrophy
NCT02726711Phase 1Active, not recruiting
- Sponsor
- Vanderbilt University
- Start
- Apr 2016
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of trimethaphan in Supine hypertension (SH), sponsored by Vanderbilt University. Primary endpoint: Percentage of increase of the y intercept of the P-V relationship at 5 years. Started Apr 2016; status: active, not recruiting.
02
Drugs
trimethaphan
03
Conditions
Supine hypertension (SH)
Beyond the preview
Go deeper on NCT02726711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726711.